Company / Operating Income per Share
Myriad Genetics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.77
FY2025
5-year range
-$4.77 / -$1.54
FY2021-FY2025
Trend
-208.9%
vs FY2024
Sector context
#168 of 201
Health Care
What the data says
Operating Income per Share changed -209% YoY in FY2025, a notable deviation from the 9-year average annual change of -84%.
Based on SEC 10-K filings.
-4.77 in FY2025.
Declined from $-3.41 to $-4.77 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 201This company -$4.77 Sector average -$3.23
▼
-47.5% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 208.9% year-over-year.
- Ranks #168 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.77 | -208.9% |
| FY2024 | -$1.54 | +54.8% |
| FY2023 | -$3.41 | -78.5% |
| FY2022 | -$1.91 | +29.1% |
| FY2021 | -$2.70 | +20.3% |
| FY2020 | -$3.39 | -632.0% |
| FY2019 | $0.64 | -64.0% |
| FY2018 | $1.77 | +195.5% |
| FY2017 | $0.60 | -68.5% |
| FY2016 | $1.90 | +17.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026